In the specialized field of biochemical inquiry, researchers frequently distinguish between signaling proteins and synthetic laboratory compounds. When navigating the literature, one often encounters the IP-10 peptide, scientifically recognized as CXCL10 (Interferon-gamma-induced protein 10 kDa). It is vital for investigators to maintain clarity between this native chemokine and other research-grade materials like Ipamorelin (10mg), often discussed in the context of growth hormone secretagogue studies.
Understanding the IP-10 (CXCL10) Signaling Protein
IP-10/CXCL10 is a critical 8.7 kDa protein belonging to the CXC chemokine family. My experience reviewing laboratory data suggests that its primary biological relevance lies in its role as a chemokine secreted in response to IFN-γ, playing a major role in the activation and regulation of inflammatory and immune responses within the body.
From an entity-focused perspective, the IP-10 (CXCL10)-derived peptide has been a subject of significant interest due to its angiostatic properties. Research indicates that this specific derivative inhibits endothelial cell function, modulating angiogenesis—a process critical for organ development and wound healing. It is well-documented that IP-10 signals through the CXCR3 receptor, which facilitates the selective attraction of T-lymphocytes and monocytes. This mechanism is why IP-10 is seen in many Th1-type human inflammatory diseases, and why it is frequently studied as a biomarker for cellular immune activation.
Distinguishing Research Compounds: Ipamorelin vs. IP-10
A common point of confusion in search queries involves the conflation of IP-10 and Ipamorelin. While their abbreviations may appear similar, they serve entirely different purposes in a laboratory setting:
* IP-10/CXCL10: A cytokine produced by monocytes, fibroblasts, and endothelial cells in response to IFNg and LPS. It is a Chemokine CXCL10 (IP-10) n important factor in autoimmune diseases, including Hashimoto’s thyroiditis and Type 1 diabetes mellitus.
* Ipamorelin (10mg): A synthetic pentapeptide growth hormone secretagogue. Unlike the inflammatory chemokine CXCL10, Ipamorelin is investigated for Ipamorelin research peptide for controlled laboratory studies focused on peptide signaling, receptor interaction, and structured research workflows. its selective interaction with the ghrelin/growth hormone secretagogue receptor (GHS IP-10 -R1a) to study endocrine signaling pathways.
When sourcing Ipamorelin research peptide, investigators typically look for high-purity (99%+) comp Importance of IP-10 as a biomarker of host immune response ounds, often referred to in shorthand as CP10 (frequently a blend of CJC-1295 and Ipamorelin). These materials are intended exclusively for in-vitro or analytical laboratory research.
Analytical Considerations for CXCL10 also known as Interferon gamma-induced protein 10 (IP-10) or small-inducible cytokine B10 is an 8.7 kDa protein that in humans is encoded by the CXCL10 Researchers
For those conducting experiments, the distinction between IP-10 (Interferon-gamma inducible Protein 10kDa) and synthetic peptides is paramount. IP-10/CXCL10 protein function is highly specific to immune modulation, whereas Ipamorelin is a synthetic peptide used in laboratory research to explore growth hormone secretagogue mechanisms.
When reviewing data, always verify the source and the specific CAS number (such as 170851-70-4 for Ipamorelin). Whether you are focusing on the CXCL10 pathway in THP1-Blue KI-IP10 cells or evaluating the efficacy of a specialized Ipamorelin peptide batch, maintaining rigorous standards for purity and documentation ensures the integrity of your research workflow.
By keeping these entities distinct—recognizing IP-10 as a member of the CXC family of chemokines involved in immune regulation and Ipamorelin as a growth hormone-releasing peptide—researchers can CP10 better navigate Importance of IP-10 as a biomarker of host immune response the complex landscape of biochemical signaling and synthetic compound application.